20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Multiplex immunofluorescence and single‐cell transcriptomic profiling reveal the spatial cell interaction networks in the non‐small cell lung cancer microenvironment

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Conventional immunohistochemistry technologies were limited by the inability to simultaneously detect multiple markers and the lack of identifying spatial relationships among cells, hindering understanding of the biological processes in cancer immunology.

          Methods

          Tissue slices of primary tumours from 553 IA∼IIIB non‐small cell lung cancer (NSCLC) cases were stained by multiplex immunofluorescence (mIF) assay for 10 markers, including CD4, CD38, CD20, FOXP3, CD66b, CD8, CD68, PD‐L1, CD133 and CD163, evaluating the amounts of 26 phenotypes of cells in tumour nest and tumour stroma. StarDist depth learning model was utilised to determine the spatial location of cells based on mIF graphs. Single‐cell RNA sequencing (scRNA‐seq) on four primary NSCLC cases was conducted to investigate the putative cell interaction networks.

          Results

          Spatial proximity among CD20+ B cells, CD4+ T cells and CD38+ T cells ( r 2 = 0.41) was observed, whereas the distribution of regulatory T cells was associated with decreased infiltration levels of CD20+ B cells and CD38+ T cells ( r 2 = −0.45). Univariate Cox analyses identified closer proximity between CD8+ T cells predicted longer disease‐free survival (DFS). In contrast, closer proximity between CD133+ cancer stem cells (CSCs), longer distances between CD4+ T cells and CD20+ B cells, CD4+ T cells and neutrophils, and CD20+ B cells and neutrophils were correlated with dismal DFS. Data from scRNA‐seq further showed that spatially adjacent N1‐like neutrophils could boost the proliferation and activation of T and B lymphocytes, whereas spatially neighbouring M2‐like macrophages showed negative effects. An immune‐related risk score (IRRS) system aggregating robust quantitative and spatial prognosticators showed that high‐IRRS patients had significantly worse DFS than low‐IRRS ones (HR 2.72, 95% CI 1.87–3.94, p < .001).

          Conclusions

          We developed a framework to analyse the cell interaction networks in tumour microenvironment, revealing the spatial architecture and intricate interplays between immune and tumour cells.

          Abstract

          • Deep learning algorithm on multiplex immunofluorescence images identified cell spatial patterns with prognostic effects in the lung cancer microenvironment.

          • Single‐cell RNA‐sequencing revealed the cell interaction networks suggested by spatial paradigm analyses.

          • Proximity among CD4+ T cells, CD20+ B cells and N1‐like neutrophils, and spatial compartmentalisation between cancer stem cells and CD8+ T cells, were associated with significantly longer disease‐free survival.

          Related collections

          Most cited references72

          • Record: found
          • Abstract: found
          • Article: not found

          Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

          This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2-fold to 3-fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied <2-fold for men and little for women. Death rates for female breast and cervical cancers, however, were considerably higher in transitioning versus transitioned countries (15.0 vs 12.8 per 100,000 and 12.4 vs 5.2 per 100,000, respectively). The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with a larger increase in transitioning (64% to 95%) versus transitioned (32% to 56%) countries due to demographic changes, although this may be further exacerbated by increasing risk factors associated with globalization and a growing economy. Efforts to build a sustainable infrastructure for the dissemination of cancer prevention measures and provision of cancer care in transitioning countries is critical for global cancer control.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

            Although genomewide RNA expression analysis has become a routine tool in biomedical research, extracting biological insight from such information remains a major challenge. Here, we describe a powerful analytical method called Gene Set Enrichment Analysis (GSEA) for interpreting gene expression data. The method derives its power by focusing on gene sets, that is, groups of genes that share common biological function, chromosomal location, or regulation. We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer. Notably, where single-gene analysis finds little similarity between two independent studies of patient survival in lung cancer, GSEA reveals many biological pathways in common. The GSEA method is embodied in a freely available software package, together with an initial database of 1,325 biologically defined gene sets.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              limma powers differential expression analyses for RNA-sequencing and microarray studies

              limma is an R/Bioconductor software package that provides an integrated solution for analysing data from gene expression experiments. It contains rich features for handling complex experimental designs and for information borrowing to overcome the problem of small sample sizes. Over the past decade, limma has been a popular choice for gene discovery through differential expression analyses of microarray and high-throughput PCR data. The package contains particularly strong facilities for reading, normalizing and exploring such data. Recently, the capabilities of limma have been significantly expanded in two important directions. First, the package can now perform both differential expression and differential splicing analyses of RNA sequencing (RNA-seq) data. All the downstream analysis tools previously restricted to microarray data are now available for RNA-seq as well. These capabilities allow users to analyse both RNA-seq and microarray data with very similar pipelines. Second, the package is now able to go past the traditional gene-wise expression analyses in a variety of ways, analysing expression profiles in terms of co-regulated sets of genes or in terms of higher-order expression signatures. This provides enhanced possibilities for biological interpretation of gene expression differences. This article reviews the philosophy and design of the limma package, summarizing both new and historical features, with an emphasis on recent enhancements and features that have not been previously described.
                Bookmark

                Author and article information

                Contributors
                drjianxing.he@gmail.com
                bruda@126.com
                liangwh1987@163.com
                Journal
                Clin Transl Med
                Clin Transl Med
                10.1002/(ISSN)2001-1326
                CTM2
                Clinical and Translational Medicine
                John Wiley and Sons Inc. (Hoboken )
                2001-1326
                01 January 2023
                January 2023
                : 13
                : 1 ( doiID: 10.1002/ctm2.v13.1 )
                : e1155
                Affiliations
                [ 1 ] Department of Thoracic Oncology and Surgery China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease the First Affiliated Hospital of Guangzhou Medical University Guangzhou China
                [ 2 ] Department of Clinical Medicine Nanshan School Guangzhou Medical University Guangzhou China
                [ 3 ] Department of Computer Science Guangdong Polytechnic Normal University Guangzhou China
                [ 4 ] Department of Artificial Intelligence Research Pazhou Lab Guangzhou China
                [ 5 ] Medical Department Genecast Biotechnology Co., Ltd Beijing China
                [ 6 ] Department of Medical Oncology The First People's Hospital of Zhaoqing Zhaoqing China
                Author notes
                [*] [* ] Correspondence

                Jianxing He, Department of Thoracic Surgery, the First Affiliated Hospital of Guangzhou Medical University; China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, China.

                Email: drjianxing.he@ 123456gmail.com

                Xu Lu, Department of Computer Science, Guangdong Polytechnic Normal University, Guangzhou 510006, China; Pazhou Lab, Guangzhou 510330, China.

                Email: bruda@ 123456126.com

                Wenhua Liang, Department of Thoracic Oncology, the First Affiliated Hospital of Guangzhou Medical University; China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, China.

                Email: liangwh1987@ 123456163.com

                Article
                CTM21155
                10.1002/ctm2.1155
                9806015
                36588094
                6ad0e7f6-fbd2-4938-a7b5-dc92a3d1d265
                © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 06 December 2022
                : 12 August 2022
                : 12 December 2022
                Page count
                Figures: 9, Tables: 1, Pages: 23, Words: 13524
                Funding
                Funded by: National Natural Science Foundation of China
                Award ID: 81871893
                Award ID: 62176067
                Funded by: Key Project of Guangzhou Scientific Research Project
                Award ID: 201804020030
                Funded by: Scientific and Technological Planning Project of Guangzhou
                Award ID: 201903010041
                Award ID: 202103000040
                Funded by: Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2019)
                Funded by: Cultivation of Guangdong College Students' Scientific and Technological Innovation (‘Climbing Program’ Special Funds)
                Award ID: pdjh2020a0480
                Award ID: pdjh2021a0407
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                January 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.3 mode:remove_FC converted:01.01.2023

                Medicine
                cell interaction networks,deep learning algorithm,multiplex immunofluorescence,single‐cell rna sequencing,tumour microenvironment

                Comments

                Comment on this article